Steve Schonfeld’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-150,000
Closed -$3.74M – 2565
2025
Q4
$3.74M Sell
150,000
-899,000
-86% -$22.7M 0.02% 649
2025
Q3
$26.7M Buy
+1,049,000
New +$25.9M 0.15% 127
2024
Q4
– Sell
-4,100
Closed -$119K – 2295
2024
Q3
$119K Sell
4,100
-145,900
-97% -$4.26M ﹤0.01% 1860
2024
Q2
$4.2M Hold
150,000
– – 0.03% 611
2024
Q1
$4.16M Buy
+150,000
New +$4.16M 0.03% 720
2023
Q4
– Sell
-163,800
Closed -$5.43M – 2143
2023
Q3
$5.43M Buy
+163,800
New +$5.79M 0.04% 522

Other funds holding PFE

Steve Schonfeld's PFE Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Pfizer (PFE) in Q3 2026: 109,942 shares worth $3.14M. The stake represents 0.01% of the portfolio and ranks #909 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in PFE as recently as Q3 2025.

Steve Schonfeld first reported a position in PFE in Q1 2016 and has held it in 30 quarters since. The position peaked at $39.6M in Q1 2024. 2,885 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Steve Schonfeld held 109,942 shares of Pfizer worth $3.14M as of Q3 2026.
  • Pfizer was a new Steve Schonfeld position in Q3 2026.
  • Pfizer made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #909 holding.
  • Steve Schonfeld first reported a position in Pfizer in Q1 2016 and has held it in 30 quarters since.
  • Steve Schonfeld's Pfizer position peaked at $39.6M in Q1 2024.
  • 2,885 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.